Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03808883
Recruitment Status : Unknown
Verified January 2019 by Misty Luminais, Case Western Reserve University.
Recruitment status was:  Not yet recruiting
First Posted : January 18, 2019
Last Update Posted : January 18, 2019
Sponsor:
Collaborators:
LGBT Community Center of Greater Cleveland
MetroHealth Medical Center
Information provided by (Responsible Party):
Misty Luminais, Case Western Reserve University

Brief Summary:
Transgender and gender nonconforming (TGNC) individuals face a number of health disparities, many of which can be tied to a lack of access to or use of primary care. Stigma and misunderstanding make simple doctor's visits into ordeals only worth enduring for the most serious of problems. This project addresses those issues by enlisting TGNC people as experts on their own experience. TGNC individuals will form a year-long cohort that will form the basis for this research. Collectively, they will define the scope of challenges faced when seeking healthcare, what medical advocacy training they desire, and how to address groups of healthcare providers and staff. Healthcare providers, including MDs, nurses, and PAs, will attend two facilitated sessions with the TGNC cohort to meet as peers with knowledge exchanged in both directions. Similar meetings will occur with clinic staff, as TGNC individuals have expressed how stigma begins from the moment they call a medical office. Our hypothesis is that when TGNC individuals are given the tools to navigate the healthcare system and the ability to speak with medical professionals as peers, rather than patients, through a participatory action research design they will be better able to access appropriate care through increased confidence and mutual support. The complementary hypothesis for medical providers is that direct interaction with a variety of TGNC individuals who articulate their needs will decrease stigma and increase comfort when treating TGNC people as patients. As a partnership between academic, medical, and community institutions, this project has the potential to directly impact the lives of TGNC individuals who participate and indirectly impact others served by the LGBT Center. This proposal works on three levels: 1) at the academic level - an assessment of participatory action research as an intervention to decrease health disparities, 2) at the individual level - the potential for individuals to increase personal knowledge and skills, and 3) at the institutional level - as actors within the TGNC community develop relationships with individual healthcare providers, medical clinics and activist groups and community partners and educational institutions are concurrently forming networks that will have positive, although probably more diffuse, impact on TGNC individuals as these institutions come together to support TGNC health care.

Condition or disease Intervention/treatment Phase
Gender Identity Behavioral: TGNC Directed Advocacy Meetings Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: All participants will be assigned to the intervention
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Understanding and Reducing Health Disparities Faced by Transgender and Gender Non-conforming (TGNC) Individuals in Cleveland Through TGNC-Directed Advocacy
Estimated Study Start Date : February 2019
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : January 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: LGBTQ+ Health


Intervention Details:
  • Behavioral: TGNC Directed Advocacy Meetings
    Series of community meetings with TGNC individuals to include meeting with health professionals to articulate barriers to access and to enter into dialogue with medical providers and staff


Primary Outcome Measures :
  1. Change in knowledge of TGNC individuals of total number of locations to receive medical care in Cleveland known [ Time Frame: 9 months - 1 year ]
    Pre/post test free list of all places medical care can be accessed - change measured in total number of answers given

  2. Change in knowledge of medical providers of total number of medical and social issues faced by TGNC individuals [ Time Frame: 3 months - 6 months ]
    Pre/post test free list of all issues TGNC individuals face - change measured in total number of answers given

  3. Change in attitude of TGNC individuals towards healthcare providers' sensitivity to transgender issues as measured by 10 Likert scale questions developed for this project [ Time Frame: 9 months - 1 year ]
    pre/post test survey of 10 Likert scale measures on a scale of 1-5

  4. Change in attitude of medical providers towards transgender issues as measured by 10 Likert scale questions developed for this project [ Time Frame: 3 months - 6 months ]
    pre/post test survey of 10 Likert scale measures on a scale of 1-5

  5. Qualitative shift in confidence of TGNC individuals in seeking medical care after the intervention based on semi-structured interviews created for this project [ Time Frame: 1 year ]
    post-intervention semi-structured interview conducted by trained anthropologist with tool developed for this project and analyzed with qualitative data analysis software for emergent themes and repetition of a priori codes

  6. Qualitative shift in confidence of medical provider in providing culturally competent medical care to TGNC individuals after the intervention based on semi-structured interviews created for this project [ Time Frame: 6 months ]
    post-intervention semi-structured interview conducted by trained anthropologist with tool developed for this project and analyzed with qualitative data analysis software for emergent themes and repetition of a priori codes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Gender Eligibility Description:   TGNC cohort must self-identify as transgender or gender nonconforming
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • self-identify as transgender or gender nonconforming
  • fluent English speaker
  • above the age of 14 years old

Exclusion Criteria:

  • non-fluent English speaker
  • below the age of 14 years old
  • does not identify as transgender or gender nonconforming

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03808883


Contacts
Layout table for location contacts
Contact: Misty Luminais, PhD 216-368-1329 misty.luminais@case.edu
Contact: Wendy Boerger 216-368-5235 wendy.boerger@case.edu

Sponsors and Collaborators
Case Western Reserve University
LGBT Community Center of Greater Cleveland
MetroHealth Medical Center
Layout table for additonal information
Responsible Party: Misty Luminais, Senior Research Associate, Case Western Reserve University
ClinicalTrials.gov Identifier: NCT03808883    
Other Study ID Numbers: IRB-2018-2194
First Posted: January 18, 2019    Key Record Dates
Last Update Posted: January 18, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Misty Luminais, Case Western Reserve University:
Barriers to Healthcare Access
Participatory Action Research
Cultural Competency